Back to Screener

Healthcare

BioCryst Pharmaceuticals, Inc.(BCRX)

Live Price

Offline

$9.90

-1.00% today

1Y Change

-7.35%

Window

Jun 26, 2025 โ†’ Jun 17, 2026

Market Cap
$1.90B
Revenue Growth
+94.1%
EPS Growth
+393.0%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 26, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

BioCryst Pharmaceuticals, Inc. (BCRX) is a Healthcare stock with a market cap of $1.90B. The stock last traded around $9.90 and down 7.3% across the available one-year price window (Jun 26, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of +94.1%, EPS growth of +393.0%, a dividend yield of 0.0%. What stands out right now is revenue +94.1%, EPS +393.0%, free cash flow +716.1% with operating margin 39.0% and ROIC 93.9%. Valuation is more restrained than many high-expectation growth names at P/E 7.2 and price/sales 2.2. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines BCRX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

BCRX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BCRX

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BCRX Max Drawdown

-35.40%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BCRX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 4, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 4, 26
โ€”
Est 0.07
โ€”
โ€”
Est 151663.3B
โ€”
May 4
โ€”
Feb 26, 26
โœ“
1.12
Est 0.07
+1500.0%
406555.0B
Est 151324.8B
+168.7%
Feb 26
โ€”
Nov 3, 25
โœ—
0.06
Est 0.07
-14.3%
159395.0B
Est 151320.4B
+5.3%
Nov 3
โ€”
Aug 4, 25
โœ“
0.15
Est 0.03
+400.0%
163353.0B
Est 149587.9B
+9.2%
Aug 4
โ€”
May 5, 25
โœ“
0.00
Est -0.07
+100.2%
145534.0B
Est 149722.0B
-2.8%
May 5
โ€”
Feb 24, 25
โœ—
-0.13
Est -0.07
-85.7%
131534.0B
Est 126636.0B
+3.9%
Feb 24
โ€”
Nov 4, 24
โ€”
-0.07
Est -0.07
0.0%
117085.0B
Est 127720.0B
-8.3%
Nov 4
โ€”
Aug 5, 24
โœ“
-0.06
Est -0.19
+68.4%
109332.0B
Est 98320.0B
+11.2%
Aug 5
โ€”
May 6, 24
โœ“
-0.17
Est -0.23
+26.1%
92761.0B
Est 85600.0B
+8.4%
May 6
โ€”
Feb 26, 24
โœ—
-0.28
Est -0.24
-16.7%
93401.0B
Est 90010.0B
+3.8%
Feb 26
โ€”
Nov 2, 23
โœ“
-0.19
Est -0.25
+24.0%
86742.0B
Est 85950.0B
+0.9%
Nov 2
โ€”
Aug 3, 23
โœ“
-0.24
Est -0.25
+4.0%
82491.0B
Est 80990.0B
+1.9%
Aug 3
โ€”
May 3, 23
โœ“
-0.28
Est -0.30
+6.7%
68778.0B
Est 71680.0B
-4.0%
May 3
โ€”
Feb 21, 23
โœ—
-0.38
Est -0.19
-100.0%
79545.0B
Est 75226.2B
+5.7%
Feb 21
โ€”
Nov 1, 22
โœ“
-0.23
Est -0.32
+28.1%
75827.0B
Est 74781.7B
+1.4%
Nov 1
โ€”
Aug 4, 22
โœ“
-0.32
Est -0.36
+11.1%
65532.0B
Est 63329.6B
+3.5%
Aug 4
โ€”
May 5, 22
โœ—
-0.40
Est -0.39
-2.6%
49923.0B
Est 51359.7B
-2.8%
May 5
โ€”
Feb 23, 22
โœ—
-0.40
Est -0.31
-29.0%
47158.0B
Est 51062.3B
-7.7%
Feb 23
โ€”
Nov 3, 21
โœ—
-0.33
Est -0.30
-10.0%
40994.0B
Est 40220.0B
+1.9%
Nov 3
โ€”
Aug 5, 21
โœ—
-0.24
Est -0.22
-9.1%
49959.0B
Est 28670.0B
+74.3%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.